A phase Ib trial of ZED 1227 for the treatment of celiac disease

Trial Profile

A phase Ib trial of ZED 1227 for the treatment of celiac disease

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2017

At a glance

  • Drugs ZED 1227 (Primary)
  • Indications Coeliac disease
  • Focus Adverse reactions
  • Most Recent Events

    • 02 May 2017 Status changed from recruiting to completed, according to a Zedira GmbH media release.
    • 19 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top